Advisors Capital Management LLC Sells 957 Shares of Danaher Corporation $DHR

Advisors Capital Management LLC lowered its stake in Danaher Corporation (NYSE:DHR) by 1.9% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 49,630 shares of the conglomerate’s stock after selling 957 shares during the quarter. Advisors Capital Management LLC’s holdings in Danaher were worth $9,804,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. Pacific Capital Partners Ltd purchased a new stake in shares of Danaher during the 1st quarter worth approximately $7,175,000. Commerzbank Aktiengesellschaft FI increased its position in Danaher by 0.8% in the first quarter. Commerzbank Aktiengesellschaft FI now owns 7,905 shares of the conglomerate’s stock worth $1,621,000 after purchasing an additional 65 shares during the last quarter. Jennison Associates LLC purchased a new stake in Danaher during the first quarter valued at $72,684,000. Lipe & Dalton lifted its position in Danaher by 0.9% during the first quarter. Lipe & Dalton now owns 21,723 shares of the conglomerate’s stock valued at $4,453,000 after purchasing an additional 200 shares during the last quarter. Finally, Diversify Advisory Services LLC purchased a new position in shares of Danaher in the 1st quarter worth $305,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 0.0%

Shares of NYSE:DHR opened at $221.25 on Friday. The business’s 50 day moving average is $205.63 and its 200 day moving average is $201.09. The stock has a market cap of $156.28 billion, a P/E ratio of 45.62, a price-to-earnings-growth ratio of 3.28 and a beta of 0.81. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $258.23. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last issued its earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same period in the prior year, the business earned $1.71 EPS. The business’s revenue for the quarter was up 4.4% compared to the same quarter last year. Sell-side analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, October 31st. Shareholders of record on Friday, September 26th were issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date was Friday, September 26th. Danaher’s dividend payout ratio is presently 26.39%.

Analyst Ratings Changes

Several equities research analysts have weighed in on DHR shares. Royal Bank Of Canada set a $241.00 price objective on Danaher in a research note on Tuesday, September 2nd. TD Cowen boosted their target price on Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Redburn Partners set a $220.00 price target on Danaher in a report on Wednesday, October 8th. JPMorgan Chase & Co. lifted their price objective on shares of Danaher from $260.00 to $270.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 22nd. Finally, Barclays increased their target price on shares of Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Eighteen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $243.39.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of the stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Georgeann Couchara sold 5,174 shares of the business’s stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the completion of the transaction, the senior vice president directly owned 2,625 shares of the company’s stock, valued at $552,352.50. This trade represents a 66.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 29,728 shares of company stock valued at $6,448,990. Company insiders own 11.20% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.